Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast

James A Warneke, Robert Berger, Cynthia Johnson, Baldassarre Stea, Hugo Villar

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

BACKGROUND: Large studies have shown a similar outcome when comparing mastectomy with lumpectomy and external beam radiation therapy in the treatment of infiltrating ductal carcinoma. However, this has not been studied extensively for invasive lobular carcinoma. We studied the pattern of recurrence and overall survival of patients treated with lumpectomy and radiation for either invasive lobular carcinoma (ILC) or combined invasive lobular carcinoma/invasive ductal carcinoma (ILC/IDC) of the breast. DESIGN: A retrospective chart review was performed for 111 patients with ILC or ILC/IDC who were diagnosed and/or treated at the university hospital between 1984 and 1994. RESULTS: Of the 111 patients, 93 had stage I or II tumors. Thirty-four patients (37%) were treated with lumpectomy and adjuvant postoperative radiotherapy with one (3%) local recurrence and a mean overall survival of 83.6 months. Fifty-nine patients (63%) were treated by modified radical mastectomy with two local recurrences (3%) and a mean overall survival of 71.7 months. CONCLUSIONS: Patients with ILC or ILC/IDC can be effectively treated with lumpectomy and radiation for stage I and II tumors while maintaining a low risk of local recurrence and equivalent overall survival.

Original languageEnglish (US)
Pages (from-to)496-500
Number of pages5
JournalAmerican Journal of Surgery
Volume172
Issue number5
DOIs
StatePublished - Nov 1996

Fingerprint

Lobular Carcinoma
Segmental Mastectomy
Breast
Radiation
Recurrence
Survival
Therapeutics
Modified Radical Mastectomy
Carcinoma, Ductal, Breast
Ductal Carcinoma
Adjuvant Radiotherapy
Mastectomy
Neoplasms
Radiotherapy

ASJC Scopus subject areas

  • Surgery

Cite this

Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. / Warneke, James A; Berger, Robert; Johnson, Cynthia; Stea, Baldassarre; Villar, Hugo.

In: American Journal of Surgery, Vol. 172, No. 5, 11.1996, p. 496-500.

Research output: Contribution to journalArticle

Warneke, James A ; Berger, Robert ; Johnson, Cynthia ; Stea, Baldassarre ; Villar, Hugo. / Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. In: American Journal of Surgery. 1996 ; Vol. 172, No. 5. pp. 496-500.
@article{54f4fc58ca4547f8b2b4eb1d65fb4eda,
title = "Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast",
abstract = "BACKGROUND: Large studies have shown a similar outcome when comparing mastectomy with lumpectomy and external beam radiation therapy in the treatment of infiltrating ductal carcinoma. However, this has not been studied extensively for invasive lobular carcinoma. We studied the pattern of recurrence and overall survival of patients treated with lumpectomy and radiation for either invasive lobular carcinoma (ILC) or combined invasive lobular carcinoma/invasive ductal carcinoma (ILC/IDC) of the breast. DESIGN: A retrospective chart review was performed for 111 patients with ILC or ILC/IDC who were diagnosed and/or treated at the university hospital between 1984 and 1994. RESULTS: Of the 111 patients, 93 had stage I or II tumors. Thirty-four patients (37{\%}) were treated with lumpectomy and adjuvant postoperative radiotherapy with one (3{\%}) local recurrence and a mean overall survival of 83.6 months. Fifty-nine patients (63{\%}) were treated by modified radical mastectomy with two local recurrences (3{\%}) and a mean overall survival of 71.7 months. CONCLUSIONS: Patients with ILC or ILC/IDC can be effectively treated with lumpectomy and radiation for stage I and II tumors while maintaining a low risk of local recurrence and equivalent overall survival.",
author = "Warneke, {James A} and Robert Berger and Cynthia Johnson and Baldassarre Stea and Hugo Villar",
year = "1996",
month = "11",
doi = "10.1016/S0002-9610(96)00227-9",
language = "English (US)",
volume = "172",
pages = "496--500",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast

AU - Warneke, James A

AU - Berger, Robert

AU - Johnson, Cynthia

AU - Stea, Baldassarre

AU - Villar, Hugo

PY - 1996/11

Y1 - 1996/11

N2 - BACKGROUND: Large studies have shown a similar outcome when comparing mastectomy with lumpectomy and external beam radiation therapy in the treatment of infiltrating ductal carcinoma. However, this has not been studied extensively for invasive lobular carcinoma. We studied the pattern of recurrence and overall survival of patients treated with lumpectomy and radiation for either invasive lobular carcinoma (ILC) or combined invasive lobular carcinoma/invasive ductal carcinoma (ILC/IDC) of the breast. DESIGN: A retrospective chart review was performed for 111 patients with ILC or ILC/IDC who were diagnosed and/or treated at the university hospital between 1984 and 1994. RESULTS: Of the 111 patients, 93 had stage I or II tumors. Thirty-four patients (37%) were treated with lumpectomy and adjuvant postoperative radiotherapy with one (3%) local recurrence and a mean overall survival of 83.6 months. Fifty-nine patients (63%) were treated by modified radical mastectomy with two local recurrences (3%) and a mean overall survival of 71.7 months. CONCLUSIONS: Patients with ILC or ILC/IDC can be effectively treated with lumpectomy and radiation for stage I and II tumors while maintaining a low risk of local recurrence and equivalent overall survival.

AB - BACKGROUND: Large studies have shown a similar outcome when comparing mastectomy with lumpectomy and external beam radiation therapy in the treatment of infiltrating ductal carcinoma. However, this has not been studied extensively for invasive lobular carcinoma. We studied the pattern of recurrence and overall survival of patients treated with lumpectomy and radiation for either invasive lobular carcinoma (ILC) or combined invasive lobular carcinoma/invasive ductal carcinoma (ILC/IDC) of the breast. DESIGN: A retrospective chart review was performed for 111 patients with ILC or ILC/IDC who were diagnosed and/or treated at the university hospital between 1984 and 1994. RESULTS: Of the 111 patients, 93 had stage I or II tumors. Thirty-four patients (37%) were treated with lumpectomy and adjuvant postoperative radiotherapy with one (3%) local recurrence and a mean overall survival of 83.6 months. Fifty-nine patients (63%) were treated by modified radical mastectomy with two local recurrences (3%) and a mean overall survival of 71.7 months. CONCLUSIONS: Patients with ILC or ILC/IDC can be effectively treated with lumpectomy and radiation for stage I and II tumors while maintaining a low risk of local recurrence and equivalent overall survival.

UR - http://www.scopus.com/inward/record.url?scp=0030297017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030297017&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(96)00227-9

DO - 10.1016/S0002-9610(96)00227-9

M3 - Article

C2 - 8942552

AN - SCOPUS:0030297017

VL - 172

SP - 496

EP - 500

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 5

ER -